Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-α signaling protected Wistar rats from diet-induced obesity and insulin resistance

Endocrinology

Volumn 149, Issue 6, 2008, Pages 2943-2951

  Liang, Huifang ^a   Yin, Bingjiao ^a   Zhang, Hailong ^a   Zhang, Shu ^a   Zeng, Qingling ^a   Wang, Jing ^a   Jiang, Xiaodan ^a   Yuan, Li ^a   Wang, Cong Yi ^b   Li, Zhuoya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HYBRID PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN TNFR1BP FC; SUCROSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TYROSINE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID DIET; MUSCLE TISSUE; NONHUMAN; OBESITY; PANCREAS ISLET; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ANIMALS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INSULIN; INSULIN RESISTANCE; L CELLS (CELL LINE); MICE; OBESITY; PLASMIDS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44249103964     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0978     Document Type: Article

References (45)

1. Naser KA, Gruber A, Thomson GA 2006 The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster? Int J Clin Pract 60:1093-1097
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM 2006 Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
3. Schinner S, Scherbaum WA, Bornstein SR, Barthel A 2005 Molecular mechanisms of insulin resistance. Diabet Med 22:674-682
4. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A 1993 Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
5. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM 1996 Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022
6. Skolnik EY, Marcusohn J 1996 Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev 7:161-173
7. Warne JP 2003 Tumour necrosis factor α: a key regulator of adipose tissue mass. J Endocrinol 177:351-355
8. Ruan H, Lodish HF 2003 Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine Growth Factor Rev 14:447-455
9. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
10. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM 1994 Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270
11. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
12. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB 1995 The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119
13. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T 1998 Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83:2907-2910
14. Lang CH, Dobrescu C, Bagby GJ 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52
15. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM 1994 Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858
16. Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM 1997 TNF-α-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46:1678-1683
17. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614
18. Schreyer SA, Chua Jr SC, LeBoeuf RC 1998 Obesity and diabetes in TNF-α receptor-deficient mice. J Clin Invest 102:402-411
19. Uysal KT, Wiesbrock SM, Hotamisligil GS 1998 Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity. Endocrinology 139:4832-4838
20. Hotamisligil GS 1999 The role of TNFα and TNF receptors in obesity and insulin resistance. J Intern Med 245:621-625
21. Hube F, Hauner H 2000 The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipocytes in primary culture. Endocrinology 141:2582-2588
22. Sethi JK, Xu H, Uysal KT, Wiesbrock SM, Scheja L, Hotamisligil GS 2000 Characterisation of receptor-specific TNFα functions in adipocyte cell lines lacking type 1 and 2 TNF receptors. FEBS Lett 469:77-82
23. Yei F, Jiang X, Li Z, Gong F, Xu Y, Feng W, Ping X 2002 [Screening for TNF-α related peptides by phage display system]. Chin J Microbiol Immunol 22:366-371 (Chinese)
24. Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, Chen G, Luo T, Guang M, Liu Y, Zhang D, Zheng S, Yang J, Gu Y, Xie X, Luo M 2003 The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim 52:401-407
25. Zhang Y, Zhuang R, Jin BQ, Ouyang WM 2005 [Preparation, purification and identification of the rabbit antibody against extracellular region of mLAIR-1]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 21:595-597 (Chinese)
26. Rigato F, Garwood J, Calco V, Heck N, Faivre-Sarrailh C, Faissner A 2002 Tenascin-C promotes neurite outgrowth of embryonic hippocampal neurons through the alternatively spliced fibronectin type III BD domains via activation of the cell adhesion molecule F3/contactin. J Neurosci 22:6596-6609
27. Molina PE, Qian L, Schuhlein D, Naukam R, Wang H, Tracey KJ, Abumrad NN 1998 CNI-1493 attenuates hemodynamic and pro-inflammatory responses to LPS. Shock 10:329-334
28. Freemark M, Avril I, Fleenor D, Driscoll P, Petro A, Opara E, Kendall W, Oden J, Bridges S, Binart N, Breant B, Kelly PA 2002 Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143:1378-1385
29. Youngren JF, Paik J, Barnard RJ 2001 Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats. J Appl Physiol 91:2240-2247
30. He Y, Yin B, Zhuoya L 2003 [The effect of TNF receptor blocking peptide on the functions of rat peritoneal macrophages.] Zhong Guo Mian Yi Xue Za Zhi 19:385-389 (Chinese)
31. He YP, Li ZY, Jiang XD, Feng W, Xu Y, Xiong P 2003 [Effects of TNF-α receptor blocking peptide on adjuvant arthritis in rats.] Yao Xue Xue Bao 38:889-892 (Chinese)
32. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R 1996 Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885
33. Paquot N, Castillo MJ, Lefebvre PJ, Scheen AJ 2000 No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab 85:1316-1319
34. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH 1987 Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555-563
35. Ryden M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P 2004 Targets for TNF-α-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 318:168-175
36. Blay JY, Chouaib S 1989 Tumor necrosis factor α (cachectin). Biological properties and role in physiopathology. Presse Med 18:975-979
37. Hotamisligil GS, Spiegelman BM 1994 Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278
38. Grunfeld C, Wilking H, Neese R, Gavin LA, Moser AH, Gulli R, Serio MK, Feingold KR 1989 Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res 49:2554-2560
39. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE 1997 Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531
40. Morimoto Y, Nishikawa K, Ohashi M 1997 KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production. Life Sci 61:795-803
41. Boden G 2001 Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 7:44-51
42. Steppan CM, Lazar MA 2002 Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23
43. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocr Rev 26:439-451
44. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM 1994 Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 94:1543-1549
45. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH, Bryer-Ash M 1998 An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNF-α)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-α. Endocrinology 139:4928-4935